These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30880594)

  • 1. Single-photon emission computed tomography (SPECT) perfusion and neuropsychological performance in mild cognitive impairment.
    Van Patten R; Greif T; Britton K; Tremont G
    J Clin Exp Neuropsychol; 2019 Jul; 41(5):530-543. PubMed ID: 30880594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between neuropsychological tests and hypoperfusion in MCI patients: anatomical labeling using xjView and Talairach Daemon software.
    Yoon HJ; Park KW; Jeong YJ; Kang DY
    Ann Nucl Med; 2012 Oct; 26(8):656-64. PubMed ID: 22777857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant correlation between cerebral hypoperfusion and neuropsychological assessment scores of patients with mild cognitive impairment.
    Yoon HJ; Park KW; Jeong YJ; Kang DY
    Nucl Med Commun; 2012 Aug; 33(8):848-58. PubMed ID: 22692580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Cuberas-Borrós G; Vinyes-Junqué G; Espinosa A; Valero S; Hernández I; Roca I; Ruíz A; Rosende-Roca M; Mauleón A; Becker JT; Castell-Conesa J; Tárraga L; Boada M
    J Alzheimers Dis; 2012; 30(1):109-20. PubMed ID: 22406443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Tc-99 m ethyl cysteinate dimer single-photon emission computed tomography and clinical presentations in patients with low cobalamin status.
    Tu MC; Lo CP; Chen CY; Huang CF
    BMC Neurol; 2015 Dec; 15():251. PubMed ID: 26630935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMPAO-SPECT Can Discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment.
    Rossini F; Zauner H; Bergmann J; Kronbichler M; Spindler I; Golaszewski S; Trinka E; Staffen W
    Curr Alzheimer Res; 2019; 16(9):843-851. PubMed ID: 31453786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different parietal hypoperfusion on neuropsychological characteristics in mild cognitive impairment.
    Yamaguchi T; Tabuchi H; Ito D; Saito N; Yamagata B; Konishi M; Takebayashi M; Ikeda M; Mimura M
    Psychogeriatrics; 2021 Jul; 21(4):618-626. PubMed ID: 34056807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
    Alegret M; Cuberas-Borrós G; Espinosa A; Valero S; Hernández I; Ruíz A; Becker JT; Rosende-Roca M; Mauleón A; Sotolongo O; Castell-Conesa J; Roca I; Tárraga L; Boada M
    J Alzheimers Dis; 2014; 41(3):739-48. PubMed ID: 24685632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional cerebral perfusion in patients with amnestic mild cognitive impairment: effect of cerebral small vessel disease.
    Lei Z; Lou J; Wu H; Chen X; Ou Y; Shi X; Xu Q; Shi K; Zhou Y; Zheng L; Yin Y; Liu X
    Ann Nucl Med; 2022 Jan; 36(1):43-51. PubMed ID: 34664230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.
    Takahashi M; Oda Y; Okubo T; Shirayama Y
    J Neural Transm (Vienna); 2017 Sep; 124(9):1109-1121. PubMed ID: 28509077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual attention deficits in Alzheimer's disease: relationship to HMPAO SPECT cortical hypoperfusion.
    Vasquez BP; Buck BH; Black SE; Leibovitch FS; Lobaugh NJ; Caldwell CB; Behrmann M
    Neuropsychologia; 2011 Jun; 49(7):1741-50. PubMed ID: 21377483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural Basis of Apathy in Patients with Amnestic Mild Cognitive Impairment.
    Kazui H; Takahashi R; Yamamoto Y; Yoshiyama K; Kanemoto H; Suzuki Y; Sato S; Azuma S; Suehiro T; Shimosegawa E; Ishii K; Tanaka T
    J Alzheimers Dis; 2017; 55(4):1403-1416. PubMed ID: 27858707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study.
    Borroni B; Agosti C; Premi E; Cerini C; Cosseddu M; Paghera B; Bellelli G; Padovani A
    Eur J Neurol; 2010 May; 17(5):703-7. PubMed ID: 20050899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficits of visuospatial working memory and executive function in single- versus multiple-domain amnestic mild cognitive impairment: A combined ERP and sLORETA study.
    Gu L; Chen J; Gao L; Shu H; Wang Z; Liu D; Yan Y; Li S; Zhang Z
    Clin Neurophysiol; 2019 May; 130(5):739-751. PubMed ID: 30903827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.